Skip to main content
Login
Contact
Subscribe
Search form
Search
The Decatur Daily Democrat
Home
Forms
Delivery Concerns
News
Sports
Obituaries
Classifieds
Place an Ad
Classified Display Ads
Photos
Videos
Games
Entertainment
Local Guide
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Ardelyx Inc
(NQ:
ARDX
)
7.070
USD
+0.170 (+2.46%)
Streaming Delayed Price
Updated: 10:36 AM EST, Jan 28, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Ardelyx Inc
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
A Look At Benzinga Pro's Most-Searched Tickers For September 4, 2019
September 04, 2019
This most-searched list is a feature included in Benzinga Pro's Newsfeed tool. It highlights stocks frequently searched by Benzinga ...
Tags
AEO
ABEO
Trading Ideas
From
Benzinga
Why Ardelyx Shares Are Sinking Today
September 04, 2019
The clinical-stage biotech's stock gave back about half of Tuesday's big gain in Wednesday morning trading.
Tags
ARDX
Market News
From
Motley Fool
10 Healthcare Stocks Moving In Wednesday's Pre-Market Session
September 04, 2019
Gainers OpGen, Inc. (NASDAQ: OPGN) stock surged 68.4% to $10.98 during Wednesday's pre-market session. The market cap stands ...
Tags
Market News
Pre/Market Outlook
KZR
From
Benzinga
The Daily Biotech Pulse: Puma Leaps, Aerie Borrows, Hepion Back In Nasdaq's Good Books
September 04, 2019
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ...
Tags
Pre/Market Outlook
RIGL
SRPT
From
Benzinga
66 Biggest Movers From Yesterday
September 04, 2019
Gainers Ardelyx, Inc. (NASDAQ: ARDX) shares rose 71.2% to close at $5.82 on Tuesday after the company's pivotal phase 3 ...
Tags
RYAM
HEBT
RDHL
From
Benzinga
Noteworthy Tuesday Option Activity: ARDX, TPB, IRBT
September 03, 2019
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Ardelyx Inc (ARDX), where a total of 2,457 contracts have traded so far, representing...
Tags
Stocks
From
Market News Video
Why Are Shares Of Ardelyx Ripping Higher?
September 03, 2019
Shares of Ardelyx Inc (NASDAQ: ARDX) wereadvancing strongly on above-average volume Tuesdayfollowing a clinical trial ...
Tags
Trading Ideas
General
News
From
Benzinga
Mid-Afternoon Market Update: Dow Down 350 Points; MAM Software Shares Surge Following Acquisition News
September 03, 2019
Toward the end of trading Tuesday, the Dow traded down 1.33% to 26053.06 while the NASDAQ fell 1.31% to 7,858.22. The S&P also fell, ...
Tags
NSSC
Market News
Earnings
From
Benzinga
44 Stocks Moving In Tuesday's Mid-Day Session
September 03, 2019
Gainers Cidara Therapeutics, Inc. (NASDAQ: CDTX) shares climbed 53% to $2.57 after the company announced it has formed a ...
Tags
HEBT
MAT
GV
From
Benzinga
Mid-Day Market Update: Napco Security Technologies Drops After Q4 Results; Cidara Therapeutics Shares Jump
September 03, 2019
Midway through trading Tuesday, the Dow traded down 1.31% to 26057.05 while the NASDAQ fell 0.94% to 7888.18. The S&P also fell, ...
Tags
Intraday Update
Markets
Commodities
From
Benzinga
Why Ardelyx Is Soaring Today
September 03, 2019
Shares jump after the clinical-stage biotech reports encouraging results from an important late-stage trial.
Tags
Market News
ARDX
From
Motley Fool
Mid-Morning Market Update: Markets Open Lower; Conn's Beats Q2 Expectations
September 03, 2019
Following the market opening Tuesday, the Dow traded down 1.46% to 26017.89 while the NASDAQ fell 1.06% to 7878.76. The S&P also ...
Tags
News
IIPR
ARDS
From
Benzinga
32 Healthcare Stocks Moving In Tuesday's Pre-Market Session
September 03, 2019
Gainers Cidara Therapeutics, Inc. (NASDAQ: CDTX) stock increased by 68.5% to $2.83 during Tuesday's pre-market session. The ...
Tags
SLS
GRFS
ALC
From
Benzinga
Ardelyx Announces Positive Results from the Pivotal Phase 3 AMPLIFY Study Evaluating Tenapanor in Dialysis Patients Who Have Uncontrolled Hyperphosphatemia Despite Phosphate Binder Treatment
September 03, 2019
The primary and all key secondary endpoints were met.
From
PR Newswire
Ardelyx to Host Conference Call on September 3 to Review Results from the Pivotal Phase 3 AMPLIFY Study
September 02, 2019
Ardelyx, Inc. (NASDAQ: ARDX), a specialized biopharmaceutical company focused on developing first-in-class medicines to improve treatment for people with cardiorenal diseases, announced that it will...
From
PR Newswire
Attention Biotech Investors: Mark Your Calendar For These September PDUFA Dates
August 28, 2019
FDA activity remained brisk in August. The FDA gave its nod for a majority of drugs that came up for review, although Vanda ...
Tags
VNDA
SRPT
FDA
From
Benzinga
55 Biggest Movers From Yesterday
August 21, 2019
Gainers SCWorx Corp. (NASDAQ: WORX) shares rose 71.1% to close at $3.73 on Tuesday. Cheetah Mobile Inc. (NYSE: CMCM) jumped ...
Tags
Market News
IBIO
IPWR
From
Benzinga
44 Stocks Moving In Tuesday's Mid-Day Session
August 20, 2019
Gainers Cemtrex, Inc. (NASDAQ: CETX) shares rose 71.1% to $2.5999 after the company reported Q3 sales up from last year. iBio, ...
Tags
News
Mid/Day Movers
HGV
From
Benzinga
72 Biggest Movers From Yesterday
August 20, 2019
Gainers DPW Holdings, Inc. (NYSE: DPW) shares jumped 133% to close at $4.80 on Monday after the company announced that its ...
Tags
HOV
EIDX
GLOB
From
Benzinga
Notable Monday Option Activity: CRY, ARDX, LULU
August 19, 2019
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in CryoLife, Inc. (CRY), where a total volume of 1,062 contracts has been traded thus...
Tags
Stocks
From
Market News Video
48 Stocks Moving In Monday's Mid-Day Session
August 19, 2019
Gainers DPW Holdings, Inc. (NYSE: DPW) shares climbed 262.6% to $7.47 after the company announced that its subsidiary, Digital ...
Tags
Biotechnology
NSPR
PACD
From
Benzinga
5 Biggest New Drug Approvals Potentially on the Way in 2019
August 19, 2019
FDA approvals for these drugs could translate to billions of dollars for a few companies.
Tags
XLRN
ITCI
ARDX
From
Motley Fool
60 Biggest Movers From Friday
August 19, 2019
Gainers Plus Therapeutics, Inc. (NASDAQ: PSTV) shares jumped 272.2% to close at $14.44 on Friday after the company reported Q2 ...
Tags
RKDA
News
VAL
From
Benzinga
Ardelyx Reports Second Quarter 2019 Financial Results and Recent Business Highlights
August 09, 2019
AMPLIFY clinical trial to read out 3Q19
From
PR Newswire
Knight Announces Filing of New Drug Submission for Ibsrela™ in Canada
June 26, 2019
Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a Canadian specialty pharmaceutical company, announced today that Knight's New Drug Submission (NDS) for Ibsrela™ (tenapanor) has been accepted for...
From
GlobeNewswire News Releases
SPSM's Holdings Could Mean 18% Gain Potential
June 20, 2019
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Ardelyx to Present at the Jefferies 2019 Global Healthcare Conference
May 30, 2019
Ardelyx, Inc. (NASDAQ: ARDX), a specialized biopharmaceutical company focused on developing first-in-class medicines to improve treatment choices for people with cardiorenal diseases, today announced...
From
PR Newswire
Analysts Expect VTHR Will Reach $147
May 16, 2019
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Ardelyx Reports First Quarter 2019 Financial Results and Recent Business Highlights
May 07, 2019
Two Pivotal Phase 3 readouts in 2H 2019
From
PR Newswire
Analysts Anticipate 13% Gains Ahead For VTWO
April 15, 2019
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.